$1.24
-0.06-4.62%
At close: -
$1.21
-0.03-2.42%
After Hours: Feb 12, 9:29 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for ZyVersa Therapeutics in recent months.
Browse guidance and forecast on all stocks.